PFE · News · 20260826N
Guidance / Outlook
PFIZER INC · 2026-08-26 · Importance 44 · Surprise 60
Third-party reporting says Pfizer increased its revenue guidance following strong second-quarter results. The report does not quantify the revised revenue outlook or specify the applicable fiscal timeframe. It says projected revenue remains under pressure as older medicines lose exclusivity and COVID-related revenue declines, while oncology and obesity pipeline programs are cited as potential longer-term growth drivers.